EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

R17 Drives Heparan Sulfate Clearance via Endolysosomal Trafficking

Pranali Bedekar, Alexander Lin, Abigail E Reeves, Meg Critcher, Gil-Suk Yang, Sean Hui, Daved H Fremont, Mia L Huang iD

Israel Journal of Chemistry · 2026-07 · 66 (4)

DOI: 10.1002/ijch.70016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Israel Journal of Chemistry, online erschienen am 20.05.2026. Verfasst von Pranali Bedekar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Skaggs Graduate School of Chemical and Biological Sciences Scripps Research 10550 North Torrey Pines Rd La Jolla CA 92037 USA. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heparan sulfate (HS) proteoglycans are information‐rich macromolecules that can orchestrate extracellular signaling and cargo uptake across diverse cellular contexts. Ligands that can engage cell surface HS possess significant potential as probes to investigate or manipulate cell–matrix interactions. Here, we show that R17, an HS‐binding protein from the rodent herpesvirus Peru, actively remodels the glycocalyx of pancreatic cancer cells. Recombinant R17 bound heparin in vitro and associated with the surface of pancreatic cancer cells to promote the dose‐dependent clearance of HS via trafficking to lysosomes. R17 also reduced wound closure without detectable cytotoxicity, indicative of the ability of R17 to suppress cellular migration. Notably, HS depletion persisted upon cation‐independent mannose‐6‐phosphate receptor knockdown, suggesting that clearance is independent of this mechanism. These findings identify R17 as an exogenous HS‐binding protein that can drive HS clearance via endolysosomal trafficking and suggest an alternative approach to modulate HS‐dependent functions.

Schlagwörter

Stichwörter der Autor:innen

endocytosisendolysosomal traffickingglycosaminoglycansheparan sulfateheparan sulfate proteoglycanslysosomepancreatic cancer

Autor:innen und Institutionen

  • Skaggs Graduate School of Chemical and Biological Sciences Scripps Research 10550 North Torrey Pines Rd La Jolla CA 92037 USA.
  • Department of Chemistry Scripps Research 10550 North Torrey Pines Rd La Jolla CA 92037 USA.
  • Departments of Pathology & Immunology, Biochemistry & Molecular Biophysics, and Molecular Microbiology Washington University School of Medicine St. Louis MO 63108 USA.

ORCID-Profile: Mia L Huang

Förderung

  • NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Bedekar, P., Lin, A., Reeves, A. E., Critcher, M., Yang, G. S., Hui, S., Fremont, D. H., & Huang, M. L. (2026). R17 Drives Heparan Sulfate Clearance via Endolysosomal Trafficking. Israel Journal of Chemistry, 66(4). https://doi.org/10.1002/ijch.70016

Vancouver

Bedekar P, Lin A, Reeves AE, Critcher M, Yang GS, Hui S, et al. R17 Drives Heparan Sulfate Clearance via Endolysosomal Trafficking. Israel Journal of Chemistry. 2026;66(4). doi:10.1002/ijch.70016

BibTeX
@article{Bedekar2026,
  author = {Bedekar, Pranali and Lin, Alexander and Reeves, Abigail E and Critcher, Meg and Yang, Gil-Suk and Hui, Sean and Fremont, Daved H and Huang, Mia L},
  title = {R17 Drives Heparan Sulfate Clearance via Endolysosomal Trafficking},
  journal = {Israel Journal of Chemistry},
  year = {2026},
  volume = {66},
  number = {4},
  doi = {10.1002/ijch.70016}
}
Kostenlos starten →